These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 16175541)

  • 1. An experimental and molecular-modeling study of the binding of linked sulfated tetracyclitols to FGF-1 and FGF-2.
    Cochran S; Li CP; Bytheway I
    Chembiochem; 2005 Oct; 6(10):1882-90. PubMed ID: 16175541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, FGF-1 binding, and molecular modeling studies of conformationally flexible heparin mimetic disaccharides.
    Liu L; Bytheway I; Karoli T; Fairweather JK; Cochran S; Li C; Ferro V
    Bioorg Med Chem Lett; 2008 Jan; 18(1):344-9. PubMed ID: 17981035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of molecular docking calculations involving FGF-1 and FGF-2.
    Bytheway I; Cochran S
    J Med Chem; 2004 Mar; 47(7):1683-93. PubMed ID: 15027859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of the four-component Ugi condensation for the preparation of sulfated glycoconjugate libraries.
    Liu L; Ping Li C; Cochran S; Ferro V
    Bioorg Med Chem Lett; 2004 May; 14(9):2221-6. PubMed ID: 15081013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The kinetics of FGF-2 binding to heparan sulfate proteoglycans and MAP kinase signaling.
    Forsten-Williams K; Chua CC; Nugent MA
    J Theor Biol; 2005 Apr; 233(4):483-99. PubMed ID: 15748910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Site-directed mutagenesis and molecular modeling identify a crucial amino acid in specifying the heparin affinity of FGF-1.
    Patrie KM; Botelho MJ; Franklin K; Chiu IM
    Biochemistry; 1999 Jul; 38(29):9264-72. PubMed ID: 10413500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solution NMR structure of a human FGF-1 monomer, activated by a hexasaccharide heparin-analogue.
    Canales A; Lozano R; López-Méndez B; Angulo J; Ojeda R; Nieto PM; Martín-Lomas M; Giménez-Gallego G; Jiménez-Barbero J
    FEBS J; 2006 Oct; 273(20):4716-27. PubMed ID: 16995857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorospectrometric analysis of heparin interaction with fibroblast growth factors.
    Li LY; Seddon AP
    Growth Factors; 1994; 11(1):1-7. PubMed ID: 7530465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligand-induced coupling versus receptor pre-association: cellular automaton simulations of FGF-2 binding.
    Gopalakrishnan M; Forsten-Williams K; Täuber UC
    J Theor Biol; 2004 Mar; 227(2):239-51. PubMed ID: 14990388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of common and specific growth factor binding sites in heparan sulfate proteoglycans.
    Chu CL; Goerges AL; Nugent MA
    Biochemistry; 2005 Sep; 44(36):12203-13. PubMed ID: 16142919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An atomic resolution structure for human fibroblast growth factor 1.
    Bernett MJ; Somasundaram T; Blaber M
    Proteins; 2004 Nov; 57(3):626-34. PubMed ID: 15382229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rerouting of fibroblast growth factor 2 to the classical secretory pathway results in post-translational modifications that block binding to heparan sulfate proteoglycans.
    Wegehingel S; Zehe C; Nickel W
    FEBS Lett; 2008 Jul; 582(16):2387-92. PubMed ID: 18538671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific inhibition of FGF-2 signaling with 2-O-sulfated octasaccharides of heparan sulfate.
    Ashikari-Hada S; Habuchi H; Sugaya N; Kobayashi T; Kimata K
    Glycobiology; 2009 Jun; 19(6):644-54. PubMed ID: 19254961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A structural and dynamic model for the interaction of interleukin-8 and glycosaminoglycans: support from isothermal fluorescence titrations.
    Krieger E; Geretti E; Brandner B; Goger B; Wells TN; Kungl AJ
    Proteins; 2004 Mar; 54(4):768-75. PubMed ID: 14997572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A focused sulfated glycoconjugate Ugi library for probing heparan sulfate-binding angiogenic growth factors.
    Liu L; Li C; Cochran S; Feder D; Guddat LW; Ferro V
    Bioorg Med Chem Lett; 2012 Oct; 22(19):6190-4. PubMed ID: 22929233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast growth factors share binding sites in heparan sulphate.
    Kreuger J; Jemth P; Sanders-Lindberg E; Eliahu L; Ron D; Basilico C; Salmivirta M; Lindahl U
    Biochem J; 2005 Jul; 389(Pt 1):145-50. PubMed ID: 15769253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Capillary electrophoresis and enzyme solid phase assay for examining the purity of a synthetic heparin proteoglycan-like conjugate and identifying binding to basic fibroblast growth factor.
    Dimitrellos V; Lamari FN; Militsopoulou M; Kanakis I; Karamanos NK
    Biomed Chromatogr; 2003 Jan; 17(1):42-7. PubMed ID: 12583005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Energetic characterization of the basic fibroblast growth factor-heparin interaction: identification of the heparin binding domain.
    Thompson LD; Pantoliano MW; Springer BA
    Biochemistry; 1994 Apr; 33(13):3831-40. PubMed ID: 8142385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural specificity in a FGF7-affinity purified heparin octasaccharide required for formation of a complex with FGF7 and FGFR2IIIb.
    Luo Y; Ye S; Kan M; McKeehan WL
    J Cell Biochem; 2006 Apr; 97(6):1241-58. PubMed ID: 16315317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-surface heparan sulfate proteoglycans are essential components of the unconventional export machinery of FGF-2.
    Zehe C; Engling A; Wegehingel S; Schäfer T; Nickel W
    Proc Natl Acad Sci U S A; 2006 Oct; 103(42):15479-84. PubMed ID: 17030799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.